Ruijuan Gao

880 total citations
42 papers, 615 citations indexed

About

Ruijuan Gao is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ruijuan Gao has authored 42 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ruijuan Gao's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ruijuan Gao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ruijuan Gao collaborates with scholars based in China, United States and Germany. Ruijuan Gao's co-authors include Kai Wang, Zongchao Han, Rajendra Narayan Mitra, Min Zheng, Yong‐Su Zhen, Wenting Lv, Chunjie Wang, Jinna Song, Xiujun Liu and Aorigele Chen and has published in prestigious journals such as Journal of Clinical Investigation, ACS Nano and Advanced Functional Materials.

In The Last Decade

Ruijuan Gao

40 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruijuan Gao China 15 269 115 83 71 66 42 615
Xinhui Zhang China 13 266 1.0× 196 1.7× 95 1.1× 95 1.3× 42 0.6× 49 853
Tadahiro Nakamura Japan 18 466 1.7× 46 0.4× 69 0.8× 95 1.3× 14 0.2× 61 855
Dhara A. Patel United States 11 263 1.0× 107 0.9× 29 0.3× 193 2.7× 31 0.5× 16 650
Gajanan Sathe India 22 649 2.4× 152 1.3× 70 0.8× 93 1.3× 12 0.2× 67 1.1k
Mary Joseph India 11 310 1.2× 56 0.5× 229 2.8× 70 1.0× 25 0.4× 31 942
Kohta Kurohane Japan 16 251 0.9× 43 0.4× 63 0.8× 121 1.7× 77 1.2× 53 863
Fattah Sotoodehnejadnematalahi Iran 16 379 1.4× 49 0.4× 55 0.7× 139 2.0× 41 0.6× 65 687
Lan Ma China 16 331 1.2× 105 0.9× 19 0.2× 115 1.6× 34 0.5× 37 887
Luyao Liu China 15 251 0.9× 68 0.6× 24 0.3× 185 2.6× 65 1.0× 85 687
Olga Witkowska‐Piłaszewicz Poland 15 256 1.0× 114 1.0× 34 0.4× 69 1.0× 24 0.4× 46 710

Countries citing papers authored by Ruijuan Gao

Since Specialization
Citations

This map shows the geographic impact of Ruijuan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijuan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijuan Gao more than expected).

Fields of papers citing papers by Ruijuan Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruijuan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijuan Gao. The network helps show where Ruijuan Gao may publish in the future.

Co-authorship network of co-authors of Ruijuan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Ruijuan Gao. A scholar is included among the top collaborators of Ruijuan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruijuan Gao. Ruijuan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Hangsheng, Binbin Cheng, Zhao‐Yang Lu, et al.. (2025). Discovery of highly potent dual GSPT1/BRD4 degraders with anti-AML activity. European Journal of Medicinal Chemistry. 288. 117381–117381. 8 indexed citations
3.
Xing, Lili, et al.. (2024). Metatranscriptomic analysis reveals the diversity of RNA viruses in ticks in Inner Mongolia, China. PLoS neglected tropical diseases. 18(12). e0012706–e0012706. 4 indexed citations
4.
Gao, Ruijuan, et al.. (2024). Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway. BMC Cardiovascular Disorders. 24(1). 535–535. 6 indexed citations
5.
Sun, Liping, Dandan Zhou, Xiaofan Wu, et al.. (2023). hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer. Journal of Medicinal Chemistry. 66(21). 14700–14715. 6 indexed citations
7.
Cao, Nan, et al.. (2022). [Emodin inhibits the proliferation and migration of human pulmonary artery smooth muscle cells by blocking SMAD2/3 signaling pathway].. PubMed. 38(8). 707–713.
9.
Gao, Ruijuan, Xueyan Peng, Huanxing Sun, et al.. (2021). Macrophage-derived netrin-1 drives adrenergic nerve–associated lung fibrosis. Journal of Clinical Investigation. 131(1). 43 indexed citations
10.
Gao, Ruijuan, Aimei Zhang, Tian Tian, et al.. (2021). The promoting role of Cx43 on the proliferation and migration of arterial smooth muscle cells for angiotensin II-dependent hypertension. Pulmonary Pharmacology & Therapeutics. 70. 102072–102072. 11 indexed citations
11.
Zhao, Jialiang, Ruijuan Gao, Yuan Tian, et al.. (2019). Intrabody against prolyl hydroxylase 2 ameliorates acetaminophen-induced acute liver injury in mice via concomitant promotion of angiogenesis and redox homeostasis. Biomedicine & Pharmacotherapy. 123. 109783–109783. 14 indexed citations
12.
Gao, Ruijuan, et al.. (2018). Developing Nanoceria‐Based pH‐Dependent Cancer‐Directed Drug Delivery System for Retinoblastoma. Advanced Functional Materials. 28(52). 47 indexed citations
13.
Tao, Lin, Dongdong Chen, Ruijuan Gao, et al.. (2017). Immunohistochemical findings in small cell neuroendocrine carcinoma of the cervix: a report of two cases. Translational Cancer Research. 6(4). 860–868. 1 indexed citations
14.
Mitra, Rajendra Narayan, Ruijuan Gao, Min Zheng, et al.. (2017). Glycol Chitosan Engineered Autoregenerative Antioxidant Significantly Attenuates Pathological Damages in Models of Age-Related Macular Degeneration. ACS Nano. 11(5). 4669–4685. 82 indexed citations
15.
Williams, Donna, Michael Hagensee, Ruijuan Gao, Danny Barnhill, & Elizabeth T. H. Fontham. (2016). The accuracy and validity of HPV testing through self-collection with tampons for cervical cancer screening. Translational Cancer Research. 5(5). 1 indexed citations
16.
Xu, Jian, Xiujun Liu, Liang Li, et al.. (2015). An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy. Oncotarget. 6(28). 26322–26334. 20 indexed citations
17.
Gao, Ruijuan, Lijuan Zhao, Xichun Liu, et al.. (2011). Methylseleninic acid is a novel suppressor of aromatase expression. Journal of Endocrinology. 212(2). 199–205. 14 indexed citations
18.
Lin, Cai, et al.. (2010). [Binding capability of lidamycin apoprotein to human breast cancer detected by tissue microarrays].. PubMed. 45(5). 582–8. 2 indexed citations
19.
Gao, Ruijuan, et al.. (2008). Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder. Urologia Internationalis. 81(1). 72–76. 8 indexed citations
20.
Gao, Ruijuan, et al.. (2005). The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters. Breast Cancer Research and Treatment. 93(2). 111–115. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026